How to appeal a UPMC Health Plan multiple myeloma (non-car-t) denial
ACA §2719 + ERISA §503 · 180-day window · 30-day decision
The framework that applies to your appeal
Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.
UPMC Health Plan-specific note: Integrated payer-provider arm of UPMC (~4M members). Western PA dominant. The Highmark-UPMC consent decree (expired June 2019) governed cross-network access historically; subsequent commercial agreements maintain some access. PA Insurance Department oversight.
What UPMC Health Plan typically denies for multiple myeloma (non-car-t)
Across UPMC Health Plan's commercial and Medicare books, denials cluster around a small number of patterns. For multiple myeloma (non-car-t), expect:
- Highmark-vs-UPMC network access disputes (historical PA consent decree)
- Specialty drug PA
- Behavioral health prior auth
- Out-of-network reductions
Treatments most often denied in this category
These are the multiple myeloma (non-car-t) treatments most often flagged for prior auth, step therapy, or medical necessity review:
- Darzalex IV
- Darzalex Faspro SC
- Sarclisa
- Tecvayli
- Elrexfio
- Talvey
How to submit the appeal to UPMC Health Plan
- Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
- Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UPMC Health Plan cited in the denial.
- File the appeal through UPMC Health Plan's portal (members: https://www.upmchealthplan.com ; providers: https://www.upmchealthplan.com/providers). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
- If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In PA, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.
Frequently asked questions
How long do I have to appeal a UPMC Health Plan multiple myeloma (non-car-t) denial?
UPMC Health Plan allows 180 days from the date on the denial letter to file an internal appeal. Standard decisions come back within 30 days; expedited decisions for urgent care typically within 72 hours.
What's the fastest way to submit a UPMC Health Plan appeal?
Members can submit through the UPMC Health Plan member portal at https://www.upmchealthplan.com. Providers should use the provider portal at https://www.upmchealthplan.com/providers. Faxed and mailed appeals are accepted but take longer.
What denials does UPMC Health Plan most often issue for multiple myeloma (non-car-t)?
Across UPMC Health Plan's book of business the common patterns include: Highmark-vs-UPMC network access disputes (historical PA consent decree); Specialty drug PA; Behavioral health prior auth. For multiple myeloma (non-car-t) specifically, expect denials tied to the FDA-approved indication, step therapy through cheaper alternatives, and prior authorization documentation gaps.
What if UPMC Health Plan denies the appeal too?
After an internal appeal denial you have the right to an external review by an independent reviewer (IRO) — request it within 4 months of the final internal denial.
Start your Multiple myeloma (non-CAR-T) appeal
Upload your UPMC Health Plan denial letter — DenialHelp drafts a physician-ready appeal in five minutes, aligned to ACA §2719 + ERISA §503.
Get started →Contact: hello@denialhelp.com